Health Catalyst, Inc. HCAT revenue by segment, product and geography
In its fiscal year ending 2025-12-31, Health Catalyst, Inc. reported revenue across 2 business segments; the largest, Technology, was $208M, 66.9% of the filed sum (+6.9% against the prior period in the same filing).
Reported segment mix
figures as filed · share of the filed sum · change vs the prior period in the same filing- Technology$208M66.9%+6.9% yoy
- Professional Services$103M33.1%-7.9% yoy
Members sum to the consolidated $311M for this period.
- Recurring Technology$208Mshare n/a+6.9% yoy
- Technology$208Mshare n/a+6.9% yoy
- Professional Services$103Mshare n/a-7.9% yoy
- Onetime Technology$0share n/ano prior
member sum exceeds the consolidated figure: this axis carries more than one breakdown, so shares are not computed.
- Technology$49.5M69.9%-3.9% yoy
- Professional Services$21.3M30.1%-23.8% yoy
Change is against the same quarter a year earlier, as reported in the same 10-Q.
Source: SEC DERA Financial Statement and Notes data sets. Dimensional XBRL facts on the business-segment, product/service and geographic axes; the engine keeps the accession of every figure. Descriptive and educational, not advice.
About these figures
Companies tag segment, product and geographic revenue as dimensional XBRL facts in their 10-K and 10-Q filings. The SEC publishes those facts in its DERA Financial Statement and Notes data sets; TrendNalysis ingests each monthly file and serves the facts exactly as filed, keyed to the accession of the filing. Shares are of the filed sum. Where a filer tags more than one breakdown on one axis, the sum exceeds consolidated revenue and no shares are computed; where the members do not add up to the consolidated figure, the residual is stated rather than hidden. Missing is never zero.
Descriptive and educational; not investment advice. Methodology and data lineage.